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Abstract 
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The vital role that membrane proteins play in cell mechanisms and the inner 
workings of disease in our bodies has been universally accepted. Thus, the study of 
protein-membrane and transmembrane interactions has become increasingly significant in 
understanding these membrane proteins. Synthetic model peptides, such as GWALP23 
(acetyl-GGALW5LALALALALALALW19LAGA-amide)—designed at the University of 
Arkansas and composed of the amino acid residues of glycine (G), alanine (A), leucine 
(L) and tryptophan (W) —provide a favorable “host” framework for investigations of the 
influence of chosen “guest” amino acids.  For example, it is of interest to know the 
consequences of having a third, centrally located, tryptophan (Trp) within the 
hydrophobic core of a well characterized, anchored, transmembrane helix.  It is crucial to 
note that the orientation and rotation of GWALP23 are sensitive to single-residue 
replacements, in part because the membrane-spanning helix exhibits only limited 
dynamic averaging of solid-state NMR observables such as the deuterium (2H) 
quadrupolar splitting. A single Trp residue was introduced in the 12th or 13th position of 
GWALP23, and specific deuterated alanine labels (2H-Ala) were included as probes 
within the core helical sequence. The 2H quadrupolar splittings from solid-state NMR 
spectra of GWALP23-W12 and GWALP23-W13 show that the peptide remains helical 
and retains a dominant preferred tilted transmembrane orientation (similar to GWALP23) 
in lipid bilayer membranes of DLPC, DMPC, and DOPC. Modified Gaussian and semi-
static treatments of the peptide dynamics yield similar conclusions.  While a central Trp 
at position 12 or 13 does not alter the characteristics of bilayer-spanning GWALP23, 
incorporation of the peptide helix into the bilayer membrane becomes more difficult.  The 
properties of Trp4,5 GWALP 23 are also being investigated for comparison with the 
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highly dynamic Tyr4,5 and the less dynamic Phe4,5 peptides.  Preliminary results through 
solid-state 2H NMR reveal Trp4,5 to be more dynamic than Phe4,5 and less dynamic than 
Tyr4,5.  Deuterium labels at Ala3 and Ala21 reveal possible fraying of the ends of selected 
helices in bilayers comprised of lipids of acyl chains of differing lengths.  The partial 
helix unwinding could help to stabilize the peptide with a central Trp residue.   
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ABBREVIATIONS 
CD, circular dichroism;  DLPC, 1,2-dilauroylphosphatidylcholine;  DMPC, 1,2-
dimyristoylphosphatidylcholine;  DOPC, 1,2-dioleoylphosphatidylcholine;  Fmoc, 
Fluorenylmethoxycarbonyl;  GALA, Geometric analysis of labeled alanines;  GWALP23, 
acetyl-GGALW(LA)6LWLAGA-[ethanol]amide;  HPLC, high-performance liquid 
chromatography;  kHz, kilohertz;  MALDI-TOF, matrix-assisted laser 
desorption/ionization-time of flight;  MRE, mean residue ellipticity;  MtBE, methyl-t-
butyl ether;  NMR, nuclear magnetic resonance;  RMSD, root mean squared deviation;  
RPM, revolutions per minute;  TFA, trifluoroacetic acid;  TFE, 2,2,2-trifluoroethanol;  
TIPS, triisopropylsilane 
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Introduction  
The study of proteins and transmembrane interactions is in the forefront of 
scientific research because of the intricate role membrane proteins play in many cellular 
processes like cell signaling and the opening and closing of voltage-gated channels (1). In 
our lab, we use synthetic model peptides (“GWALP” families; see Table 1) to analyze the 
intricate relationship between peptides and lipid bilayers. The GWALP peptides arose 
from an original WALP model peptide which contained four aromatic residues that 
served as anchors for a membrane-spanning helix (3)(8)(14).  Additionally, the length of 
the hydrophobic core of the WALP peptide was altered and analyzed with various lengths 
of phosphatidylcholine lipids to study hydrophobic mismatch in WALP peptides and 
lipid interactions. Though useful for studying peptide mismatch, the WALP peptides 
were highly dynamic and were not good model peptides to analyze the effects of altering 
a single residue on the peptide (17).  
The GWALP23 model peptide, a cognate of the WALP peptide, was developed to 
reduce the high dynamics that was seen in the WALP model peptide. The GWALP23 
model peptide consists of two anchoring tryptophan (Trp/W) residues instead of the 
initial four, which (remarkably) allows for greater stability and lower dynamics of the 
transmembrane helix (15)(16). GWALP23 (GGALW(LA)6LWLAGA) contains one 
tryptophan residue on each end (at positions 5 and 19), and a repeating leucine-alanine 
helical core sequence (5) (10).  The repeating leucine-alanine helical core prefers the 
hydrophobic environment of the membrane, whereas the Trp residues prefer a location 
near the lipid-water interface (11). The leucine-alanine core accentuates the peptide’s 
response to the thickness of the membrane (that is a result of hydrophobic mismatch). 
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This hydrophobic mismatch is from the difference between the thickness of the lipid 
bilayer’s hydrophobic portion and the length of the peptide’s hydrophobic core. The 
mismatch can affect both the orientation of the peptide in the lipid bilayer and the 
alignment of the lipid themselves (8).  This sensitivity of the GWALP23 peptide makes it 
the preferred model for studying the influence of single and multiple residue 
replacements on peptide orientation and dynamics. 
 
 
 
 
 
Figure 1: 3D representation of the favored GWALP23 model peptide is shown along 
with the indole rings of W5 and W19 in the 23-residue sequence 
 The orientation and dynamics of GWALP23 and a tyrosine derivative (containing 
Y5 instead of W5) are well understood (5). In this project, the GWALP23 peptide was 
modified by adding a central tryptophan in the 12th or 13th position in the hydrophobic 
core of the GWALP23 peptide. Alanine residues in the helical core were labeled with 
deuterium in order to study the dynamics and orientation of the peptide in lipid bilayers 
by solid-state deuterium NMR. Depending on the intent of the study, alanine can be 
labeled either in the core positions of 7 and 9, 11 and 13, 15 and 17, or in the end 
positions of 3 and 21. In the alanine pairs that are labeled, the alanine closer to the N-
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terminal is labeled with 50% deuterated alanine and the other alanine is labeled with 
100% deuterated alanine.  
  
 
 
 
 
Figure 2: The GWALP23-W12 is shown on the left and GWALP23-W13 is shown on 
the right  
The orientations of GWALP23-W12 and GWALP23-W13 were investigated in 
bilayers of DLPC (12:0), DMPC (14:0), and DOPC (18:1). It can be hypothesized that 
the indole ring of all tryptophans, including the central W12 or W13, will prefer the 
membrane-water interface. Results for GWALP23-W12 and GWALP23-W13 will be 
compared to those of GWALP23 to observe the changes that have occurred in peptide 
orientation (specifically the helix tilt and rotation).  
In addition to studying the effects of a central tryptophan, the effects of altering 
the aromatic anchors on a GWALP23 are also studied. After a single anchor 
peptide ,Y5GWALP23, was initially synthesized and found to have similar dynamics to 
that of GWALP23, another model peptide with two tyrosine residues, Y4,5GWALP23, 
was created to study the influence of an ‘extra’ aromatic residue in peptide/lipid 
interactions (5). Unlike Y5GWALP23, Y4,5GWALP23 displayed a large difference in its 
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dynamics in comparison to GWALP23. The Y4,5GWALP23 model peptide seemed to 
have a much higher dynamic averaging, perhaps a result of the multiple aromatic tyrosine 
anchors, than that of GWALP23. A third model peptide, F4,5GWALP23, was later 
analyzed and displayed a lowered dynamic averaging in comparison to GWALP23 and 
especially Y4,5GWALP23 (12) . To better study the effect of altering the type of ‘extra’ 
aromatic residue anchor on peptide behavior and orientation, W4,5GWALP23 was 
investigated and compared to both Y4,5GWALP23 and F4,5GWALP23.  
 
 
 
 
  
                    Figure 3: Model for W4,5GWALP23 
W4,5GWALP23 , like GWALP23-W12 and GWALP23-W13 will be studied in 
DLPC, DMPC, and DOPC lipid bilayers. Additionally, Nuclear Magnetic Resonance 
(NMR) can be used to study the orientation of the peptide in the different lipids and can 
also be used for tilt analysis (performed through either a semi-static or Gaussian 
calculation method) (9).  The tilt analysis will contribute to the understanding of the 
behavior of peptides with multiple aromatic anchoring residues. 
To study the partial unwinding of the ends of the transmembrane helix, alanines 
on the ends of the peptide (at positions 3 and 21) are labeled with 2H-Ala. Positions 3 and 
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21 are located 18 residues apart in the sequence of the peptide. Because an alpha helix 
geometry requires 3.6 amino acids per turn of the helix, this places Ala 3 and Ala 21 in 
the same radial position on the helix, separated by exactly five helical turns. This study 
provides an opportunity to monitor the unwinding of the alpha helix at the N and C 
termini. If both residues are part of the helix, they should give identical quadrupolar 
splittings in 2H NMR. If the ends are indeed unwound, the quadrupolar splittings for Ala3 
and Ala21 will differ and will not lie on the quadrupolar wave from the orientation 
analysis of the labeled Ala residues within the core of the peptide. The labeled ends will 
allow for the thorough analysis of the influence of an extra tryptophan, specifically a 
central tryptophan, on the unwinding of the transmembrane helix ends. 
 The focus of this work is to study the effects of an extra tryptophan residue. 
GWALP23-W12 and GWALP-W13 probe the influence of a central tryptophan in 
comparison to GWALP23. W4,5GWALP23 allows for the comparison between the 
dynamic averaging of the various ‘extra’ aromatic residues (W, Y or F) at the 4th and 5th 
positions. Finally, 2H-labels are used to label the alanine at position 3 and 21 to 
specifically study the effect of a central tryptophan on the possibility of unwinding of the 
ends of a transmembrane helix domain.  The various peptides analyzed as a part of the 
project are listed in Table 1 below.  
 
 
 
 
12 
 
 
                                    
                        
 
 
 
 
 
 
Materials and Methods  
Name Sequence 
GWALP23 Ac-GGA3LWLA7LA9LA11LA13LA15LA17LWLA21GA-EtNH2 
GWALP23-W12 Ac-GGA3LWLA7LA9LA11WA13LA15LA17LWLA21GA-EtNH2 
GWALP23-W12 Ac-GGA3LWLA7LA9LA11WA13LA15LA17LWLA21GA-EtNH2 
GWALP23-W12 Ac-GGA3LWLA7LA9LA11WA13LA15LA17LWLA21GA-EtNH2 
GWALP23-W13 Ac-GGA3LWLA7LA9LA11LWLA15LA17LWLA21GA-EtNH2 
GWALP23-W13 Ac-GGA3LWLA7LA9LA11LWLA15LA17LWLA21GA-EtNH2 
W4,5-GWALP23 Ac-GGA3WWLA7LA9LA11LA13LA15LA17LWLA21GA-EtNH2 
W4,5-GWALP23 Ac-GGA3WWLA7LA9LA11LA13LA15LA17LWLA21GA-EtNH2 
W4,5-GWALP23 Ac-GGA3WWLA7LA9LA11LA13LA15LA17LWLA21GA-EtNH2 
*Deuterated Alanines are underlined as A in the sequence*                                                       
Ac=acetyl, EtNH2=ethanolamine 
Table 1. Model Peptide Sequence:  The table below displays the sequence of 
GWALP23 and the peptides I have synthesized as a part of my project  
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Solid Phase Peptide Synthesis with 2H Labels 
 Peptides with deuterium labeled alanines were synthesized using an applied 
Biosystems 433A Peptide Synthesizer (7).  The Fmoc-ala-d4 was made by members in 
the lab as described in (5). For the amino acids that comprise the peptide, 0.57 mmoles of 
the amino acid was weighed out and placed in separate cartridges.  The peptide was 
labeled with two deuterium labeled alanines (one 50% labeled and one 100% labeled) at 
the core of the peptide at positions 7 and 9, 11 and 13, 15 and 17, or the ends of the 
peptide at position 3 and 21. For the labeled alanines, 0.28 mmoles of Fmoc-Ala-d4 with 
0.28 mmoles of Alanine were placed in a cartridge (for the 50% deuterium labeled 
Alanine). 0.57 mmoles of only fmoc-Ala-d4 was used for the 100% deuterium labeled 
Alanine.  The peptide was synthesized from the carboxy end of a Wang resin (company), 
achieved by ordering the cartridges from the C to N-terminal. During the synthesis, the 
“FastMoc” method was used on the synthesizer and a series of deprotecting, coupling, 
and rinsing was performed (6).   
Cleavage of the Peptide:  
After the completion of the peptide synthesis, the peptide is cleaved from the resin 
with Ethanolamine.  The resin with the peptide is placed in a glass vial and 11 mL of 
Dichloromethane and 4 mL of Ethanolamine is added to the resin. The glass vial is 
wrapped in foil and placed on a shaker for 48 hours at 480 min-1. After the 48 hours, the 
resin slurry is filtered with a 10mL glass filter. The resin solution is rinsed with 5mL of 
Dichloromethane four times and then 5 mL of TFE four times. After the rinse, the 
rotovap is set up and used to minimize the volume of the filtered liquid. After rotovaping, 
the resulting peptide substance is equally poured into two centrifuge tubes and filled with 
DI H20 (about 80% of the total volume of the centrifuge tube should be DI water). The 
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tubes are placed in a refrigerator and allowed to precipiate in DI water overnight. The 
next day, the JA-20 rotor is used to centrifuge the peptide mixture at 14,000 RPM for two 
hours. The resulting supernatant should be disposed and the pellet should be dried on the 
vacuum line overnight.  
Crude GWALP Quantitation and Purification:  
 After the peptide has been cleaved off of the resin, the amount of peptide that has 
been recovered needs to be determined. This process is called peptide quantitation. To 
quantitate the peptide, 0.5 mL of TFE is added into the centrifuge tubes with the dried 
peptide. A UV-Vis sample is prepared by mixing 2 L of the dried peptide with 1.5 mL 
of Methanol. The UV-Vis is blanked with methanol and the sample is run at 280 nm. The 
resulting spectra and the optical density (at 280nm), allows for the calculation of the total 
milligrams of peptide that is present. To test the peptide, analytical HPLC is run with a 
1L aliquot of the peptide solution (diluted to 1mg/ml with TFE). The sample is then 
prepped for mass spectrometry with 50 L of the peptide is diluted with 450 L of TFE. 
After the peptide cleavage, the peptide is ready to purify using the Semi-prep HPLC.  
Reverse-Phase High Performance Liquid Chromatography (RP-HPLC) with the Hitachi 
L1700 system and the Zorbax RX-C8 column, 9.4 mm x 250mm ( Agilent Technology). 
The HPLC machine is first purged and a desired gradient is set at 95-99% for the 
GWALP23 with an extra tryptophan. A test injection of 10 L is initially injected to 
determine the approximate peak position (time the peptide will come off the machine). 
After the test injection, the range of the RP-HPLC is set to 10 and a 500L aliquot of the 
peptide is injected. The purified product is usually collected after 23-25 minutes and then 
dried. Finally, the purified peptide is quantitated to determine how much pure peptide (in 
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milligrams) is collected. For this, the peptide is redissolved in 1 mL of TFE and a UV-Vis 
sample is made with 10 L of the peptide and 990L of MeOH. Again, from the Optical 
Density at 28nm, the weight of the total peptide (in mg) can be calculated. After 
rechecking the peptide wih MALDI-TOF mass spectrometry  with a 50 L aliquot o the 
peptide and 450 L of TFE), the peptide is aliquoted for solid-state 2H NMR and circular 
dichroism (CD) and tryptophan emission fluorescence spectroscopy. For the solid-state 
2H NMR , 1.3 mols of the peptide is aliquoted . For the CD and Trp fluorescence, 
0.0625 mols is measured out. The solvent is evaporated under N2 for an hour. The 
samples are then lyophilized by adding 0.5 mL of acetonitrile and 0.5 mL of H20 to the 
dried peptide. The solution is frozen in liquid N2 and left under vacuum overnight.  
Mass Spectrometry  
The mass of the mass spectrometry spectra, allows for the verification of our 
intended peptide by comparing expected and actual mass of peptide.  The molecular mass 
of the peptide was confirmed by MALDI- TOF mass spectrometry (MS) MALDI run by 
the University of Arkansas-Arkansas Statewide Mass spectrometry. The satellite peaks 
that are observed represent the different ionization states of the peptide. As described, 
peptides can also be purified using the semi-preparative HPLC to eliminate 
miscellaneous substances.  
Circular Dichroism Spectroscopy 
When working with peptides, it is important to know the structural conformation 
of the peptide. The secondary structure can be ascertained by running a circular 
dichroism (CD) sample. For CD, our peptides (with a central tryptophan or a tryptophan 
at the 4th position) are incorporated into small unilamellar lipid vesicles (SUVs) in DLPC, 
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DMPC, DOPC lipids. For CD, the samples were prepared by using 0.0625 mols of 
peptide from the stock solution with a 1:40 peptide to lipid ratio. In making the CD 
sample, 50:50 acetonitrile: water is added to the 0.0625 mols of peptide. Then, 2.5 
mols of lipid (DLPC, DMPC, or DOPC) is added to the peptide and acentonitrile:water 
solution. The mixture of peptide and lipid is dried under N2 gas and put under vacuum for 
48 hours to remove the solvent.  
Tryptophan Emission Fluorescence Spectroscopy:  
Tryptophan fluorescence spectroscopy is used to observe the membrane burial 
depth of tryptophan (both the central tryptophan and the tryptophan in position 4) in 
SUVs made of DLPC, DMPC, and DOPC lipid bilayers.  Samples for tryptophan 
fluorescence were prepared by performing a 1:10 dilution of the circular dichroism 
samples (with a final concentration around 10 M) . The machine used for tryptophan 
fluorescence was the ISS Photon Counting Spectrofluorometer with the VINCI software 
(ver. 1.6. SP7). While samples were running, they were excited at 280 nm (the excitation 
wavelength for Trp) and the emission was recorded at 300 to 450nm. The emission 
measurement is scanned at a rate of 60nm/min with 5mm excitation and emission slit 
widths. The excitation pathlength was 10nm and the emission path length was 1nm.   
Oriented Sample Preparation:   
Oriented Samples made for NMR spectroscopy were prepared in a 1:40 peptide to 
lipid ratio using DLPC, DMPC, and DOPC lipid membranes. 1.33 mols of peptide and 
90mols of a lipid with 45% (w/w-water/peptide-lipid) hydration were made.  To prepare 
the oriented samples, 40 glass plates were placed in two separate petri dishes (20 glass 
plates per each petri dish).  The 1.3 mols of peptide was dissolved in1 0.5mL of TFE. 
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The 14 L of peptide was mixed with 1.5 mL of MeOH. The solution was then placed in 
UV-Vis spectrometry and an absorbance reading was taken at 280 nm. From the 
absorbance, the amount of lipid required for the NMR samples was calculated. The 
amount of lipid was then added to the peptide solution and dried under nitrogen flow and 
then under vacuum overnight. To the dried peptide/lipid film, 1 mL (95% methanol and 
5% H20) was added. Using a 50 L syringe, the peptide/lipid solution was added evenly 
to the 40 glass slides on the petri dish. The glass plates were dried under vacuum in a 
desiccator for 48 hours. The final step of the oriented NMR sample preparation was 
hydration and stacking the glass plates. The dried plates were hydrated using about 1.2 
L of deuterium depleted water. The water (about 3-4 drops per plate) was used as the 
‘glue’ to stack the 40 glass plates. Once the plates were stacked, they were inserted into a 
cuvette. The, empty glass plates were then added to the outside of the stack to fill the 
cuvette. Finally, the cuvette was sealed with a glass square cover using epoxy glue. Once 
the cuvette was sealed twice (with one hour between the first and second seal), the plates 
was placed inside a dark, heating plate at 40 C for several days (until sample looks clear).  
 
  
  
 
 
Figure 4: A visual representation of preparing an oriented NMR sample is shown below 
31P NMR:  
1. 2. 
3a. 
3b. 
4. 
β=0° 
β=90° 
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A type of NMR called, 31P NMR spectroscopy is used to verify bilayer alignment. 
The sample was run at 50 ºC on a Bruker Avance 300 spectrometer (Billerica, MA) in both 
β=0° orientation (where the bilayer is parallel to the applied magnetic field) and β=90º 
orientation (where the bilayer is perpendicular to the applied magnetic field).   
2H NMR:  
Similar to 31P NMR, solid-state 2H NMR at 50 °C on a Bruker Avance 300 
spectrometer. The samples were run at β=0° and β=90°. The resulting spectrum gives 
information about quadrupolar splitting that will serve useful in creating a tilt analysis to 
study the behavior of the peptides in various lipids.  
Tilt Analysis:  
From the 2H quadrupolar splittings (Δνq) that was collected in various lipids 
(DLPC, DMPC, DOPC) with different set of alanines labels, the orientation of the peptide 
in the lipid bilayers was determined. Two methods of calculations, GALA fit and modified 
Gaussian were used to perform a semistatic model with variable parameters. The 
parameters for the calculations are the tilt of helix τ, helix rotation ρ, and Szz, a principal 
order parameter.  This principal order parameter gives more information about the overall 
motion of the peptide relative to the orientation of the peptide.  
Results  
After the target peptides were synthesized and purified, their molecular masses 
were confirmed by MALDI-TOF mass spectrometry. From the resulting mass spectrum, 
the expected mass of (2378 + 8 for the deuterons + 23 for sodium) can be compared with 
the actual mass of 2408.4 as shown on the spectrum.  
 
[M + Na]
+
 
2408.4 
+8 
2
H 
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Figure 5: The figure below is the mass spectrum for W4,5-GWALP23 
From the displayed isotope distributions for W4,5 GWALP23, it can be seen that 
the expected mass of 2377.9 Da for W4,5 GWALP23 matches the actual mass of W4,5 
GWALP23 (which includes the mass of Na+).  (Successive peaks in each of the (+4) and 
(+8) “envelopes” indicate different content of 13C (1.1% natural abundance) versus 12C in 
a peptide having about 100 carbon atoms.)  
 After verification that the desired peptide had been synthesized, an estimate of the 
secondary structure of the peptide was assessed using circular dichroism (CD) 
spectroscopy. The repeating Leu-Ala sequence in the core of the GWALP23 peptides 
prefers an alpha–helical secondary structure that is in the hydrophobic region of the lipid 
bilayer.  
+4 
2
H 
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Figure 6: CD spectra for GWALP23, GWALP23-W12, and GWALP23-W13 in DMPC 
vesicles 
Each CD spectrum in Figure 6 is characteristic of an alpha-helical secondary 
structure, with the expected characteristic minima observed at 208 nm and 222 nm.  
Minor differences among the three spectra could be due to complex interactions of the 
polarized light with the multiple Trp residues.   
 GWALP peptides could potentially produce nonlamellar phases like the inverted 
hexagonal and cubic phases of the phosphatidycholine lipids (DLPC, DMPC, DOPC) 
when there is negative mismatch (at a high peptide concentration) (4). The proper 
alignment of the lipid bilayers can be verified by 31P NMR. The peptide/lipid oriented 
samples in the three lipids (DLPC, DMPC, DOPC) were all verified to have aligned 
bilayers. The spectra display a single peak at expected place for the 31P resonance in both 
 = 0° (membrane normal parallel to the applied magnetic field) and  = 90° 
(perpendicular to the applied magnetic field).  
21 
 
 
 
 
 
 
Figure 7:  31P NMR spectra at both β = 0° and β = 90° sample orientations (overlaid) in 
DLPC, DMPC and DOPC, showing signals characteristic of aligned lipid bilayers 
The 31P NMR spectra display peaks at around +28 ppm β= 0° and -14ppm for β = 
90°.   The peak shapes are indicative of relatively well-aligned lipid bilayers.  Some 
unaligned lipids are evident from the smaller peaks at -14 ppm in the β = 0° spectra, 
which are more sensitive to the lipid alignment.  
 An effective method to study peptide incorporation and approximate location in 
various lipid membranes is through tryptophan fluorescence emission spectroscopy. 
Specifically for this project, there are three tryotphans. The emission spectra will 
represent an average of the depths of the three tryptophan residues of the peptide in the 
membrane. The λmax that is determined through tryptophan fluorescence varies depending 
upon the polarity of the environment around the indole ring. A λmax of 320-325 nm 
indicates a deeply buried tryotphan within the membrane, a value of 335-345 nm 
indicates a tryptophan at the water/membrane interface, and a value of 350-360 nm is 
indicative of tryptophan in water solution (2)(9).  
 
W13 
W12 
DLPC DMPC DOPC 
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Table 3. Tryptophan Fluorescence Emission Results:  The table below displays the 
fluorescence emission λmax values for the various GWALP23 and the derivative peptides 
excited at 295nm  
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Figure 8: Tryptophan fluorescence emissions spectra for GWALP23 and selected 
derivative peptides having one, two or three Trp residues 
As seen in the figure above, the λmax for all the peptides is mostly between 325-
330nm, suggesting the tryptophans on all of the peptides are somewhat buried within the 
membrane.  
 Finally, peptide behavior and orientation in various lipid bilayers can be studied 
by performing solid-state 2H NMR with the prepared oriented samples. As described, the 
outer tryptophans (one at each end of the peptide) are expected to aid in the stabilization 
of the peptide at the membrane-water interface. Another important factor is the extent of 
hydrophobic mismatch between the length of the peptide and the thickness of the lipids. 
In the core of the peptides, I incorporated two deuterated alanines in positions 7/9, 11/13, 
or 15/17. These 2H-labeled alanines allow for the analysis of peptide interaction and 
orientation in the lipids through the use of solid-state 2H NMR spectroscopy. In 
deuterium (2H), the nucleus is a quadrupole, giving two sets of resonance peaks for the 
CD3 group. The distance between the pair of peaks for each alanine methyl (CD3) group 
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(the 2H quadrupolar splittings) was then measured. The quadrupolar splittings, Δνq, that 
are observed in the solid-state 2H NMR spectra, vary based on the orientation of each 
CD3 groups with respect to the external magnetic field.  
  
 
 
Figure 9: This is an example spectra from the 2H NMR analysis from an aligned lipid-
bilayer sample of W4,5-GWALP23 containing a GWALP peptide with two deuterated 
alanines at positions 15 (50% deuerated alanine) and 17 (100% deuterated alanine)   
By measuring the distance between the respective peaks and finding the 
quadrupolar splittings (Δνq), the peptide orientation in the lipid membrane can later be 
understood through GALA (Geometric Analysis of Labeled Alanines) and modified 
Gaussian calculation methods (5)(12)(14).  Values for στ were fixed for calculation (15º 
for DLPC and 9º for DOPC) in the modified Gaussian analysis (12).   
Table 4. Quadrupolar splittings for GWALP23-W12: Quadrupolar splittings ((Δνq) in 
kHz) for labeled alanines in GWALP23-W12.  β=0° sample orientation. Temperature (º 
C) 
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Figure 10:  The figure above displays the solid-state 2H NMR for GWALP23-W12 in the 
β=90º orientation. The spectra on row A displays GWALP23-W12 peptides with 
deuterated alanines in position 7 (100%) and 9 (100%). The spectra on row B display the 2H 
NMR results for GWALP23-W12 with alanines labeled at position 15 (50%) and 17 (100%) 
 
Table 5. Quadrupolar splittings for GWALP23-W13: Quadrupolar splittings (Δνq) for 
labeled alanines (β=0°) in GWALP23-W13 
 
 
 
 
 
A 
B 
DLPC DMPC DOPC 
26 
 
 
 
 
 
 
 
 
Figure 11:  The figure above displays the solid-state 2H NMR for GWALP23-W13 in the 
β=90º orientation. The spectra on row A displays GWALP23-W12 peptides with 
deuterated alanines in position 7 (50%) and 9 (100%). The spectra on row B display the 2H 
NMR results for GWALP23-W13 with alanines labeled at position 15 (50%) and 17 (100%) 
Table 6. Quadrupolar splittings for W4, 5-GWALP23: Quadrupolar splittings (Δνq) 
(kHz) for labeled alanines (β=0°) in W4, 5GWALP23 and related peptides 
 
 
 
 
 
A 
B 
DLPC DMPC DOPC 
27 
 
 
 
 
 
Figure 11:  The figure above displays the solid-state 2H NMR for W4,5-GWALP23 in the 
β=90º orientation. The spectra on row A display the 2H NMR results for W4,5-GWALP23  
with alanines labeled at position 15 (50%) and 17 (100%)  
In DLPC, the shortest lipid, the quadrupolar splittings for W4,5 GWALP23 range 
from 3.3 to 17.4 kHz, F4,5 GWALP23 ranges from 1.8 to 20.7 kHz. From the rather 
similar results seen in Table 5, it can be concluded that F4,5 GWALP23 nevertheless 
seems to tilt to a slightly greater degree or tends to be less dynamic than W4,5 GWALP23.  
The reason for the small difference is unknown but could relate to the differing properties 
of the different Phe and Trp aromatic rings.  
In addition, from Tables 3, 4, and 5, it is evident that the labeled alanines in each 
lipid have different kHz quadrupolar splitting values, indicating that each helix is tilted. If 
the helix were perfectly straight in the membrane, the different labeled alanines would 
have the same quadrupolar splitting values.  
With the quadrupolar splittings, further calculations to determine the tilt and 
rotation are made by performing tilt analysis using the GALA and modified Gaussian 
methods (12) (14). Both forms of calculations use the following equation (1) in their 
calculations:  
A 
DLPC DMPC DOPC 
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In the above equation,  represents the angle of the peptide in relation to the 
applied magnetic field. h
qQe2
 in the equation is a known quadrupolar coupling constant 
(168 kHz). The equation displays the relationship between the 2H quadrupolar splittings 
value (Δνq) and the orientation of the peptide (the angle θ that is between the alanines of 
Cα and Cβ) with the external magnetic field (either 0º or 90º)  .  Equation (1) can be fitted 
to any set of Δνq values.  In GALA Fit, this θ value can also be described through 
equation (2):  
  ]tanρcossin[cosθ IIII   
 
In equation (2), the
 
ε// is the angle between Cα-Cβ and the peptide axis. This 
coupling constant accounts for the C-D with no dynamic averaging. In the calculation, 
the Szz,, and   values are determined. The Szz is the principal order parameter which 
describes overall motion of the peptide such as the wobbling of the molecule or 
vibrations (13). The  is the tilt of the peptide in the bilayer, and  is the rotation of the 
helix based on the glycine at position one. 
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Table 7. GALA Fit DLPC Calculations: Calculations of tilt (), Szz, and rotation 
() through the GALA fit method comparing GWALP, GWALP23-W12, and 
GWALP23-W13 in DLPC (12 carbons) 
 
 
 
Table 8. Modified Gaussian Calculations DLPC Results: Calculations of tilt (), Szz, 
and rotation () through the modified Gaussian method comparing GWALP, GWALP23-
W12, and GWALP23-W13 in DLPC (12 carbons) 
 
 
 In tables 6 and7, the tilt () and rotation () can be compared between the peptides 
with a central tryptophan and the regular GWALP23 peptide. The GALA Fit method 
shows the tilt for GWALP23 to be 20.7°, the tilt for GWALP23-W12 to be 17.0° and the 
tilt for GWALP23-W13 to be 18.7°. All the values for tilt, regardless of the type of 
peptide, seem to have tilt values very similar to each other (between 17-21). Similarly, 
in the modified Gaussian method, the rotation for GWALP23 is calculated to be 304° and 
the rotation for GWALP23-W12 is 326°. The rotation, like the tilt, does not differ much 
between peptides in DLPC lipid bilayers. 
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Table 9. GALA Fit DMPC Calculations: The table below shows the calculations of tilt 
(), Szz, and rotation () through the GALA fit method comparing GWALP, GWALP23-
W12, and GWALP23-W13 in DMPC (14 Carbons) 
 
 
 
Table 10.Modified Gaussian Calculations DMPC Results: The table below shows the 
calculations of tilt (), Szz, and rotation () through the modified Gaussian comparing 
GWALP, GWALP23-W12, and GWALP23-W13 in DMPC (14 Carbons) 
 
 
 
GALA fit and modified Gaussian calculations for GWALP, GWALP23-W12 and 
GWALP23-W13 in DMPC lipid bilayer give tilt values of 9.0°, 10.0°, and 9.3° 
respectively in the GALA Fit model. Similarly, the modified Gaussian gives tilt values of 
13° and 16° for GWALP23 and GWALP23-W12 respectively (in DMPC). Like in 
DLPC, both calculation methods demonstrate that the tilt does not change significantly 
whether there is a central tryptophan or not. The GALA Fit calculations show the rotation 
(p) to be 311° for GWALP23, 312 GWALP23-W12, and 300° for GWALP23-W13. It 
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can thus be concluded that both the tilt and rotation do not vary as a result of altering the 
GWALP23 sequence by adding a central tryptophan.  
Table 11. GALA Fit DOPC Calculations: The table below shows the calculations of tilt 
(), Szz, and rotation () through the GALA fit method comparing GWALP, GWALP23-
W12, and GWALP23-W13 in DOPC (18 Carbons) 
 
 
Table 12. Modified Gaussian Calculations DOPC Results: The table below shows the 
calculations of tilt (), Szz, and rotation () through the modified Gaussian method 
comparing GWALP, GWALP23-W12, and GWALP23-W13 in DOPC (18 Carbons) 
 
 
 
 In DOPC, the GALA fit method calculates the tilt to be 6° for GWALP23 and 
6.7° for GWALP23-W12. The modified Gaussian determines the rotation to be 321° for 
GWALP23 and 330° for GWALP23-W12. Both the tilt and rotation of the peptide stay 
pretty consistent in DOPC regardless of the presence of a central tryptophan. 
 It can be concluded from GALA fit and modified Gaussian tilt analysis in DLPC, 
DMPC, and DOPC that the orientation of the peptide is largely unaffected by a central 
tryptophan.  Nevertheless, I have observed that the samples are more difficult to make 
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and the NMR signal-to-noise ratio is less when a central tryptophan is present in the 
peptide helix.  
 In addition to studying the orientation and behavior of peptides with a central 
tryptophan, it is also a point of interest to study the possibility of ‘ends-fraying’ of 
peptide helices with a central tryptophan.  The possible fraying near the ends of helices of 
GWALP23-W12 or GWALP23-W13 could lead to stabilization of the helix in the 
membrane. To investigate the ends, deuterium labels were incorporated in residues A3 
and A21 of selected peptides.  If there is helix unwinding, the Δνq values will differ 
between these alanines, and either A3 or A21, or both of them, will not be part of the helix 
 
 
 
 
 
Figure 10: A.  Solid-state 2H NMR spectra for GWALP23-W12 with Ala3 and Ala21 
labeled.  B.  Helical wheel position graph from GALA analysis that shows that the Ala3 
and Ala21 Δνq values do not fit the core helical wheel  
 With the quadrupolar splitting data, the helical wheel position graph is made to 
display a visualization of where Ala3 and Ala21 are in relation to the helical wheel defined 
by the core leucine-alanine residues of the peptide. It is evident that Ala3 and Ala21 are 
both far from the helical wheel, indicating fraying of both ends. Additionally, the 
Ala 3, 11.3kHz 
Ala 21, 4.3kHz 
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quadrupolar splitting values (kHz) for Ala3 and Ala21 are far from being identical; 
instead, they are 11.3 and 4.3 kHz respectively. With different kHz values for the two 
deuterium labeled alanines, separated by an exact helical repeat distance of 18 residues, it 
is determined that there is unwinding at the ends of the GWALP23-W12 peptide.  
Discussion 
Through this project, the following principles can be understood: (1) Although 
there is a centrally located tryptophan (in position 12 or 13) incorporated into the 
GWALP23 model peptide, it exerts little influence on the orientation  or dynamics of the 
GWALP23 helix in DLPC, DMPC, or DOPC. (2) Though a central tryptophan (W12 or 
W13) does not affect the tilt or rotation of a GWALP23 model peptide, it is nevertheless 
more difficult to incorporate the peptide into some lipid bilayers, especially those of 
DOPC. There is a perceived difficulty in burying the central Trp residue, especially in 
GWALP23-W13. (3) The 2H quadrupolar splittings observed to date for W4,5GWALP23 
are somewhat smaller than those for GWALP23 or F4,5GWALP23, perhaps indicating 
increased motional averaging when W4 and W5 are present together.  The dynamic 
averaging with W4/W5 appears to be intermediate between the previously studied cases of 
F4/F5 (low dynamics) and Y4/Y5 (high dynamics).  (4) The analysis of solid-state 2H 
NMR of GWALP23-W12 with deuterated alanines 3 and 21 shows that the ends of the 
transmembrane helix fray or unwind.  
 A central tryptophan in position 12 or 13 in a GWALP23 model peptide would be 
expected to favor the membrane/water interface because of the amphipathic indole group 
on the tryptophan. As seen by quadrupolar splitting (Δνq) magnitudes and the 
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corresponding 2H NMR spectra, it can be concluded that GWALP23-W12 and 
GWALP23-W13 exhibit little change in their orientation compared to the regular 
GWALP23 model peptide. Though solid-state 2H NMR indicates that the principal 
orientation of GWAPL23 is not affected by incorporating a centrally located tryptophan, 
there is indication that the central tryptophan poses some difficulty for peptide 
incorporation into lipid bilayers (especially DOPC).  It is especially difficult to bury the 
central tryptophan in GWALP23-W13 in DOPC lipid bilayers.  
In addition to the labeling the alanines in the core helix, the labeling of Ala3 and 
Ala21 in GWALP23-W12 lends insight into the unwinding of the ends of the 
transmembrane helix. It can be concluded from the quadrupolar splitting (Δνq) 
magnitudes that the fraying of the helix ends is evident. The unwinding of the ends of the 
helix is significant as it could be important for stabilizing the peptide in a tilted 
orientation and minimizing the motion of the transmembrane helix. 
 The extra tryptophan added in the 4th position of W4,5-GWALP23 is used to study 
the dynamics induced by an additional tryptophan on the GWALP23 peptide in 
comparison to an additional phenylalanine or tyrosine.  The results show that the helix 
dynamic averaging decreases as the polarity of the paired aromatic residues decreases in 
the series YY > WW > FF.  These results could be important for understanding of 
membrane protein dynamics generally.  In this context, extensions of the studies reported 
here to cholesterol-containing membranes would be of interest.  
 GWALP23 peptides serve as an effective model for understanding the role of 
transmembrane helices in biological functions. Results from specific alterations, such as 
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those presented in this thesis, of the basic GWALP23 model sequence (like the addition 
of a central tryptophan) allow us to learn principles that underlie the behavior of 
membrane proteins as a whole.  
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